MAPK1 and metabolic dysfunction-associated steatotic liver disease: The levels of the MAPK pathway-related proteins P38 and ERK1/2 and their phosphorylation changed significantly in NAFLD mouse liver tissue, while the alterations were partially recovered after PRPM intervention.